Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

There are few approved drugs available for the treatment of patients with non-muscle invasive bladder cancer (NMIBC) and none have been approved in the twenty-first century. Four drugs; thiotepa in 1959, BCG Tice in 1989, BCG Connaught in 1990, and valrubicin in 1998, have been approved for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarow, Jonathan, Maher, V. Ellen, Tang, Shenghui, Ibrahim, Amna, Kim, Geoffrey, Sridhara, Rajeshwari, Pazdur, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Clinical Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832566/
https://www.ncbi.nlm.nih.gov/pubmed/27088122
http://dx.doi.org/10.3233/BLC-150016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832566/
https://www.ncbi.nlm.nih.gov/pubmed/27088122
http://dx.doi.org/10.3233/BLC-150016

Ejemplares similares